Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05960864 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chinese Spondyloarthritis Inception Cohort (CESPIC)

Study acronym: CESPIC
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 17, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: Feb 2024 to Sep 2024v3
  2. Start date: Sep 2023 to Feb 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Southwest Hospital, China
13 trials monitored
See all monitored trials
Crohn's Disease
642 trials monitored
See 34 trials at risk
Ulcerative Colitis
624 trials monitored
See 38 trials at risk
Psoriasis
591 trials monitored
See 24 trials at risk
and 2 more diseases
The Chinese Spondyloarthritis Inception cohort (CESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in China on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of CESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). CESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: reactive arthritis, acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.
Trial Details
NCT Number NCT05960864
Lead Sponsor Southwest Hospital, China
Conditions
(from sponsor)		 Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), Non-radiographic Axial Spondyloarthritis (Nr-axSpA), Axial Psoriatic Arthritis (axPsA), Acute Anterior Uveitis (AAU), Crohn Disease (CD), Ulcerative Colitis (UC), Reactive Arthritis (ReA)
Related terms Arthritis, Reactive, Colitis, Ulcerative, Crohn Disease, Non-Radiographic Axial Spondyloarthritis, Spondylitis, Ankylosing, Uveitis, Anterior
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov